摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-{7-[5-(acetylaminomethyl)-2-oxo-oxazolidin-3-yl]-1,2,4,5-tetrahydro-benzo[d]azepin-3-yl}-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid | 848194-17-2

中文名称
——
中文别名
——
英文名称
7-{7-[5-(acetylaminomethyl)-2-oxo-oxazolidin-3-yl]-1,2,4,5-tetrahydro-benzo[d]azepin-3-yl}-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
英文别名
7-[7-[5-(Acetamidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
7-{7-[5-(acetylaminomethyl)-2-oxo-oxazolidin-3-yl]-1,2,4,5-tetrahydro-benzo[d]azepin-3-yl}-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid化学式
CAS
848194-17-2
化学式
C30H31FN4O7
mdl
——
分子量
578.597
InChiKey
PJHDFNBNMQJFIQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    42
  • 可旋转键数:
    7
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    129
  • 氢给体数:
    2
  • 氢受体数:
    10

文献信息

  • Antibacterial agents
    申请人:Hagen Susan
    公开号:US20050070523A1
    公开(公告)日:2005-03-31
    Compounds of formula I and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula I as well as pharmaceutically acceptable compositions comprising compounds of formula I. Compounds of formula I as disclosed herein can be used in a variety of applications, including using the invention compounds to treat bacterial infections.
    本发明公开了化学式I的化合物及其制备方法。还公开了制备具有生物活性的化学式I化合物的方法,以及包含化学式I化合物的药学上可接受的组合物的制备方法。如本文所述的化学式I化合物可用于各种应用,包括使用发明化合物治疗细菌感染。
  • ANTIBACTERIAL AGENTS
    申请人:Warner-Lambert Company LLC
    公开号:EP1670793A1
    公开(公告)日:2006-06-21
  • US7304050B2
    申请人:——
    公开号:US7304050B2
    公开(公告)日:2007-12-04
  • [EN] ANTIBACTERIAL AGENTS<br/>[FR] AGENTS ANTIBACTERIENS
    申请人:WARNER LAMBERT CO
    公开号:WO2005026161A1
    公开(公告)日:2005-03-24
    Compounds of formula (I) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula (I) as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compounds of formula (I) as disclosed herein can be used in a variety of applications, including using the invention compounds to treat bacterial infections. Formula (I).
查看更多